CPI-1205

· Constellation Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CPI-1205, covering 2025-10-29 to 2025-10-29. Get the full timeline:

Most recent: Clinical Trial Update: ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer [Phase 1, Phase 2]

See pricing